Current Report Filing (8-k)
April 05 2018 - 6:14AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) off The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
March 14, 2018
CANNABIS
SCIENCE, INC.
(Exact
name of registrant as specified in charter)
Nevada
|
000-28911
|
91-1869677
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
19800
MacArthur Blvd., Suite #300
Irvine,
California
|
92612
|
(Address
of principal executive offices)
|
(Zip
Code)
|
1-888-263-0832
Registrant’s
telephone number
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item
1.01
|
Entry
into a Material Definitive Agreement.
|
On
March 14, 2018, Cannabis Science, Inc. (the “Company”), entered into s Share Purchase Agreement (the “Bottle
It Agreement”) with Bottle It, Inc. (“Bottle It”), whereby it purchased all of Bottle It’s shares, rights
assets, contracts, technology, intellectual property, titles and interests in Bottle It (collectively the “Bottle It Assets”).
The purchase price for the Bottle It Assets is the issuance of 10 million restricted common shares. The Closing Date of the Bottle
It Agreement is set for on or before June 9, 2018.
Also,
on March 14, 2018, Cannabis Science, Inc. (the “Company”), entered into a Share Purchase Agreement (the “Novus
Agreement”) with Novus Beverage Solutions Corp. (“Novus”), whereby it purchased all of Novus’ shares,
rights assets, contracts, technology, intellectual property, titles and interests in Novus (collectively the “Novus Assets”).
The purchase price for the Novus Assets is the issuance of 5 million restricted common shares. The Closing Date of the Novus Agreement
is set for on or before June 9, 2018.
Established
in 2014, Bottle It manufactures various preforms for various bottled waters, energy drinks and vitamin shots, tinctures, drops,
various pill bottles, sprays, and various food containers for rice, flour, milk, dry food mixes, spices, mixed nuts, cookies,
and the list goes on. Bottle It is a PET injection-mold and blow-mold manufacturer servicing the food and beverage industry
that has reported approximately $1,500,00.00 in revenues each year for 2016 and 2017 consecutively.
Novus
was established in December 2016, and perform the services of filling the plastic bottles with waters and various beverage and
energy drinks with its bottling and packaging equipment since 2017.
In
addition to high-quality stock products, Bottle It excels in the customization of bottles and containers – from concept
to production, and its team of highly-skilled professionals create customer-driven product packaging while maximizing quality
and container creativity. Bottle It partners with expert tool makers to create custom molds, making its customers’ visions
a reality by deciding the height, shape, and embossed features of the bottle. All products and product waste are recyclable.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
CANNABIS
SCIENCE, INC.
|
|
|
|
|
|
Date:
April 4, 2018
|
By:
|
/s/ Raymond
C. Dabney
|
|
|
|
Raymond
C. Dabney, President & C.E.O.
|
|